Yishai Ofran

Israel

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Anna Czyz

Medical University of Silesia

POLAND

View details

Yu Fujita

JAPAN

View details

Jacqueline Cloos

NETHERLANDS

View details

Brian A. Jonas

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yishai Ofran

Research Interests

Explore related searches

Contact this professor

Articles (11)

Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia

Early death in acute promyelocytic leukemia: time to redefine risk groups.

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors

Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment.

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation

Spontaneous arising of a lymphoblastoid B-cell line harbouring a pre-leukemic DNMT3A mutation in acute myeloid leukaemia cell culture.

Alignment of single-cell trajectories by tuMap enables high-resolution quantitative comparison of cancer samples.

Daratumumab - New indications revolving around "off-targets".

A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence.

Collaborators (4)

Anna Czyz

Yu Fujita

Jacqueline Cloos

Brian A. Jonas

Make your next move.